iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
66 hedge funds and large institutions have $48.8M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
–
Holders Change %
0%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
21
Reduced
19
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Jane Street
New York
|
$11.2M |
| 2 |
2
Morgan Stanley
New York
|
$5.43M |
| 3 |
CCA
3
Clearwater Capital Advisors
Hoffman Estates,
Illinois
|
$1.23M |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$4.15M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$901K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| – | -$20 | -1 | Closed |
|
77
Fidelity Investments
Boston,
Massachusetts
| – | -$20 | -1 | Closed |
|